The Nasdaq Biotechnology Index fell by 2%. Among the constituent stocks, Jyong Biotech dropped by 20.95%, BridgeBio Pharma fell by 15.21%, Sionna Therapeutics decreased by 15.12%, Abcellera Biologics declined by 14.98%, and Editas Medicine fell by 14.62%. Gilead Sciences rose by 2.15%, Silence Therapeutics increased by 5.12%, Erasca went up by 5.69%, and Phibro Animal Health surged by 22.02%
The Nasdaq Biotechnology Index fell by 2%, with component stock Jyong Biotech down 20.95%, BridgeBio Pharma down 15.21%, Sionna Therapeutics down 15.12%, Abcellera Biologics down 14.98%, and Editas Medicine down 14.62%. Gilead Sciences, on the other hand, rose by 2.15%, with Silence Therapeutics up 5.12%, Erasca up 5.69%, and Phibro Animal Health up 22.02%